Literature DB >> 24902808

Analyses of the similarity and difference of global gene expression profiles in cortex regions of three neurodegenerative diseases: sporadic Creutzfeldt-Jakob disease (sCJD), fatal familial insomnia (FFI), and Alzheimer's disease (AD).

Chan Tian1, Di Liu, Wei Xiang, Hans A Kretzschmar, Qing-Lan Sun, Chen Gao, Yin Xu, Hui Wang, Xue-Yu Fan, Ge Meng, Wei Li, Xiao-Ping Dong.   

Abstract

Neurodegenerative disease is a general designation for the disorders that are progressive loss of structure or function and final death of neurons, including Alzheimer's, Parkinson's, Huntington's, prion diseases, etc. In this study, we comparatively analyzed 21 individual microarray data sets of the cortex tissues from 11 sporadic Creutzfeldt-Jakob disease (sCJD), 3 fatal familial insomnia (FFI), 3 Alzheimer's disease (AD), and 4 normal controls. After normalization, a collection of 730 differently expressed sets (DESets) were obtained by comparison of the data of three diseases with their original controls. Principal component analysis (PCA) showed a background-related distribution within the groups of FFI, AD, and normal control, but two apparently different subgroups within the group of sCJD were observed. Review of the clinical materials of 11 sCJD patients identified the difference in brain PrP(Sc) deposits between two subgroups. Hierarchical cluster analysis illustrated the relatively independent clusters of normal controls, FFIs, six sCJD cases (subgroup 1) with more PrP(Sc) deposits, respectively, while an overlapped cluster of five cases of sCJD2 (subgroup 2) with less PrP(Sc) deposits and AD patients. Despite of the presence of special gene expressions, many common features were found among those neurodegenerative diseases. The most commonly changed biological processes (BPs) were signal transduction, synaptic transmission, and neuropeptide signaling pathway. The most commonly changed pathways were MAPK signaling pathway, Parkinson's disease, and oxidative phosphorylation. Our data here provide the similarity and difference in global gene expressions among the patients with sCJD, FFI, and AD, which may help to understand the common mechanism of neurodegenerative diseases.

Entities:  

Mesh:

Year:  2014        PMID: 24902808     DOI: 10.1007/s12035-014-8758-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  34 in total

1.  Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178.

Authors:  R Medori; P Montagna; H J Tritschler; A LeBlanc; P Cortelli; P Tinuper; E Lugaresi; P Gambetti
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

Review 2.  The mTOR pathway and its role in human genetic diseases.

Authors:  Margit Rosner; Michaela Hanneder; Nicol Siegel; Alessandro Valli; Christiane Fuchs; Markus Hengstschläger
Journal:  Mutat Res       Date:  2008-06-11       Impact factor: 2.433

3.  Genes regulated in MPTP-treated macaques and human Parkinson's disease suggest a common signature in prefrontal cortex.

Authors:  Markus Storvik; Marie-Jeanne Arguel; Sandra Schmieder; Audrey Delerue-Audegond; Qin Li; Chuan Qin; Anne Vital; Bernard Bioulac; Christian E Gross; Garry Wong; Jean-Louis Nahon; Erwan Bezard
Journal:  Neurobiol Dis       Date:  2010-03-02       Impact factor: 5.996

4.  Comparative analysis of gene expression profiles between cortex and thalamus in Chinese fatal familial insomnia patients.

Authors:  Chan Tian; Di Liu; Qing-Lan Sun; Chen Chen; Yin Xu; Hui Wang; Wei Xiang; Hans A Kretzschmar; Wei Li; Cao Chen; Qi Shi; Chen Gao; Jin Zhang; Bao-Yun Zhang; Jun Han; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2013-02-21       Impact factor: 5.590

5.  1H, 13C and '5N resonance assignments of GABARAP, GABAA receptor associated protein.

Authors:  Takahide Kouno; Kazunori Miura; Takashi Kanematsu; Masahiro Shirakawa; Masato Hirata; Keiichi Kawano
Journal:  J Biomol NMR       Date:  2002-01       Impact factor: 2.835

6.  The stimulation of inducible nitric-oxide synthase by the prion protein fragment 106--126 in human microglia is tumor necrosis factor-alpha-dependent and involves p38 mitogen-activated protein kinase.

Authors:  C Fabrizi; V Silei; M Menegazzi; M Salmona; O Bugiani; F Tagliavini; H Suzuki; G M Lauro
Journal:  J Biol Chem       Date:  2001-04-20       Impact factor: 5.157

7.  Dual modulation of ERK1/2 and p38 MAP kinase activities induced by minocycline reverses the neurotoxic effects of the prion protein fragment 90-231.

Authors:  Alessandro Corsaro; Stefano Thellung; Katia Chiovitti; Valentina Villa; Alessandro Simi; Federica Raggi; Domenico Paludi; Claudio Russo; Antonio Aceto; Tullio Florio
Journal:  Neurotox Res       Date:  2009-02-26       Impact factor: 3.911

8.  Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene.

Authors:  R Medori; H J Tritschler; A LeBlanc; F Villare; V Manetto; H Y Chen; R Xue; S Leal; P Montagna; P Cortelli
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

9.  Fatal familial insomnia: clinical and pathologic study of five new cases.

Authors:  V Manetto; R Medori; P Cortelli; P Montagna; P Tinuper; A Baruzzi; G Rancurel; J J Hauw; J J Vanderhaeghen; P Mailleux
Journal:  Neurology       Date:  1992-02       Impact factor: 9.910

10.  p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy.

Authors:  Serhiy Pankiv; Terje Høyvarde Clausen; Trond Lamark; Andreas Brech; Jack-Ansgar Bruun; Heidi Outzen; Aud Øvervatn; Geir Bjørkøy; Terje Johansen
Journal:  J Biol Chem       Date:  2007-06-19       Impact factor: 5.157

View more
  10 in total

1.  Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain.

Authors:  Sarah C Hopp; Nathan A Bihlmeyer; John P Corradi; Charles Vanderburg; Angela M Cacace; Sudeshna Das; Timothy W Clark; Rebecca A Betensky; Bradley T Hyman; Eloise Hudry
Journal:  J Neurochem       Date:  2018-09-07       Impact factor: 5.372

2.  Proteomic Analyses for the Global S-Nitrosylated Proteins in the Brain Tissues of Different Human Prion Diseases.

Authors:  Li-Na Chen; Qi Shi; Bao-Yun Zhang; Xiao-Mei Zhang; Jing Wang; Kang Xiao; Yan Lv; Jing Sun; Xiao-Dong Yang; Cao Chen; Wei Zhou; Jun Han; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2015-09-21       Impact factor: 5.590

3.  Sequence Alterations of Cortical Genes Linked to Individual Connectivity of the Human Brain.

Authors:  Qilong Xin; Laura Ortiz-Terán; Ibai Diez; David L Perez; Julia Ginsburg; Georges El Fakhri; Jorge Sepulcre
Journal:  Cereb Cortex       Date:  2019-08-14       Impact factor: 5.357

4.  The Three Glycotypes in the London Classification System of Sporadic Creutzfeldt-Jakob Disease Differ in Disease Duration.

Authors:  Blair Ney; Dhamidhu Eratne; Victoria Lewis; Luke Ney; Qiao-Xin Li; Christiane Stehmann; Steven Collins; Dennis Velakoulis
Journal:  Mol Neurobiol       Date:  2021-04-26       Impact factor: 5.590

5.  Strategies of Functional Foods Promote Sleep in Human Being.

Authors:  Yawen Zeng; Jiazhen Yang; Juan Du; Xiaoying Pu; Xiaomen Yang; Shuming Yang; Tao Yang
Journal:  Curr Signal Transduct Ther       Date:  2014-12

6.  Proteomics analyses for the global proteins in the brain tissues of different human prion diseases.

Authors:  Qi Shi; Li-Na Chen; Bao-Yun Zhang; Kang Xiao; Wei Zhou; Cao Chen; Xiao-Mei Zhang; Chan Tian; Chen Gao; Jing Wang; Jun Han; Xiao-Ping Dong
Journal:  Mol Cell Proteomics       Date:  2015-01-23       Impact factor: 5.911

7.  Identification of molecular signatures associated with sleep disorder and Alzheimer's disease.

Authors:  Lucong Liang; Jing Yan; Xiaohua Huang; Chun Zou; Liechun Chen; Rongjie Li; Jieqiong Xie; Mika Pan; Donghua Zou; Ying Liu
Journal:  Front Psychiatry       Date:  2022-08-04       Impact factor: 5.435

Review 8.  Biomarkers for sporadic Creutzfeldt-Jakob disease.

Authors:  Sanam Soomro; Chandra Mohan
Journal:  Ann Clin Transl Neurol       Date:  2016-04-25       Impact factor: 4.511

Review 9.  Insight into the Molecular Imaging of Alzheimer's Disease.

Authors:  Abishek Arora; Neeta Bhagat
Journal:  Int J Biomed Imaging       Date:  2016-01-10

10.  RNA editing alterations define manifestation of prion diseases.

Authors:  Eirini Kanata; Franc Llorens; Dimitra Dafou; Athanasios Dimitriadis; Katrin Thüne; Konstantinos Xanthopoulos; Nikolaos Bekas; Juan Carlos Espinosa; Matthias Schmitz; Alba Marín-Moreno; Vincenzo Capece; Orr Shormoni; Olivier Andréoletti; Stefan Bonn; Juan María Torres; Isidre Ferrer; Inga Zerr; Theodoros Sklaviadis
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-06       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.